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Introduction
The efficacy of local  anaesthesia for outpatient
haemorrhoidectomy has long been established both in the
local and foreign literature. The technique has been proven
reliable, safe and inexpensive. Furthermore, it allows for early
ambulation and discharge after surgery.1–5 This is particularly
important for busy outpatient departments where concerns
about serving an increasing volume of patients must be
balanced by cost-containment. In our institution, the number
of ambulatory haemorrhoidectomy cases often is limited by
the efficiency of the anaesthetists in giving regional anaesthesia.
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Our division, therefore, decided to implement a policy whereby
more patients undergoing outpatient haemorrhoidectomy be
treated under local anaesthesia, to be given by the surgeons
themselves.
Unfortunately, pain and discomfort often accompany the
injection and infiltration of local anaesthesia into the perianal
area. In order to avoid this, Nivatvongs described a different
technique, wherein the initial infiltration of the anaesthetic
is done intra-anally, above the dentate line.6 However, this
technique is difficult for surgical residents to perform and
has not gained widespread acceptance. A more common
practice is to sedate the patient prior to the infiltration of local
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OBJECTIVE: The study was undertaken to evaluate the efficacy of eutectic lidocaine/prilocaine (EMLA) cream
for decreasing pain during local anaesthetic infiltration for outpatient haemorrhoidectomy.
METHODS: Ninety-eight patients were randomly assigned either to receive EMLA or placebo. The creams were
applied 45 minutes prior to injection of a lidocaine/bupivacaine mixture using a diamond-shaped perianal block.
All participants were blinded to the specific medication received. They were asked to rate pain and levels of
acceptability using a pre-validated pain scale and questionnaire.
RESULTS: There were 49 patients in each group. The baseline characteristics between the two groups were
similar. Forty patients (82%) in the EMLA group and 42 patients (86%) in the placebo group reported only mild
pain during injection and infiltration of the lidocaine/bupivacaine mixture. The mean rank pain scores were
49.11 and 48.89, respectively (p = 0.886, not significant).
CONCLUSION: While outpatient haemorrhoidectomy under local anaesthesia was generally well tolerated,
there was no statistically significant difference between EMLA cream and placebo for decreasing pain during
anaesthetic infiltration. (Asian J Surg 2002;26(1):26–30)
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anaesthesia, but this requires intravenous cannulation and
closer monitoring of the patients. Others advocate alkalinizing
the anaesthetic solution with sodium bicarbonate, claiming
that the acidic nature of the anaesthetic is the main reason for
the pain during infiltration.7 We tried these methods, but our
experience shows that they are not always effective, and that
some patients still suffer pain during infiltration of the local
anaesthetic.
A eutectic mixture of lidocaine and prilocaine (5%, EMLA)
cream (AstraZeneca, Sodertalje, Sweden) is the first topical
anaesthetic developed that penetrates intact skin. The efficacy
of EMLA for the treatment of pain during cutaneous procedures
such as biopsies, dermal testing, intravenous cannulation and
spinal taps has been well established in several randomized
controlled trials and systematic reviews.8–14 The usual adult
dose is 2 to 5 g under an occlusive dressing for 20 to 120 minutes
prior to the procedure. Some authors have demonstrated that
the minimal effective application of EMLA is 45 minutes.15
The evidence for efficacy of EMLA in the literature
prompted us to speculate on its usefulness in decreasing the
pain during infiltration of local anaesthesia for outpatient
haemorrhoidectomy. Only one study using EMLA for these
procedures has been performed, but this was a randomized
trial comparing general anaesthesia to EMLA with local
anaesthesia.16 It did not evaluate EMLA versus placebo. The
aim of this study was to determine the effectiveness of EMLA
5% cream for decreasing pain during injection of local
anaesthesia in adult patients undergoing elective, outpatient
haemorrhoidectomy.
Patients and methods
This study was a randomized, double-blind, placebo-controlled,
parallel-group clinical trial, with prior approval from our
Institution’s Ethics Review Board. Voluntary, written, informed
consent was obtained from all patients prior to enrolment and
allocation. Ninety-eight patients with symptomatic grade III
or IV internal haemorrhoids, mixed haemorrhoids, and/or
external haemorrhoids scheduled for elective outpatient
surgery were recruited into the study. Sample size calculations
were based on estimated group pain score means of 2.0 for
group 1 (experimental group receiving EMLA) and
3.5 for group 2 (control group receiving placebo), and a
within-group standard deviation of 2.5, with an estimated
sample size of 49 participants per group. Only patients between
18 and 65 years of age with voluntary, written, informed
consent to participate in the study were included. Patients
with known allergy to any of the study medications and
those with moderate to severe co-morbid conditions such
as cardiac disease, hypertension, renal failure, diabetes,
immunocompromised conditions and pregnant women were
excluded from the study. Allocation was through simple
randomization using a table of random numbers, which were
then sealed in envelopes and opened just before the procedure.
The creams containing either EMLA or placebo were applied
at least 45 minutes before the scheduled operation. This was
done by an assigned co-investigator, with the patients lying
in the left lateral decubitus position. Five grams of EMLA
5% cream was applied to the patient’s perianal area for the
experimental group, and 5 g of commercially available white
moisturizing cream was applied to patients in the control
group. The patients were blinded as to what was applied. A
20 x 20-cm plastic occlusive dressing was then taped over the
area, and the patients were asked to sit in the waiting area. Just
prior to surgery, the patients were again placed in the left
lateral decubitus position and the cream was wiped off to make
sure the surgeon was blinded as to which cream was applied.
The local anaesthetic was composed of 10 mL of 2%
lidocaine, 10 mL of 0.5% bupivacaine, 3 mL of sterile water,
2.5 mL of NaHCO3 and 0.25 mL 1:10,000 epinephrine solution.
It was injected subcutaneously by the surgeon using a
30-gauge needle initially, then deep into the anal submucosa
and sphincters using a longer 25-gauge needle. The infiltration
technique was standardized, using the commonly practised
diamond-shaped perianal block. Approximately 10 to 12 mL
of local anaesthetic was given on each side, and the surgeon
made sure that the infiltration was done slowly, taking
approximately 5 minutes to complete. No sedatives were
given. The haemorrhoidectomy was performed in the jack
knife position, using the open Milligan-Morgan technique.
The patients were discharged immediately after the surgery
if no serious problems were noted. They were subsequently
seen at the outpatient clinics for weekly follow-up for 4 weeks.
Baseline data were recorded and included the variables of
age, gender and type of haemorrhoids. Outcomes were
measured using two standard questionnaire forms, one for the
patients and the other for the surgeons. The rating scales
ranged from 0 (no pain/very satisfied) to 5 (severe pain/
extremely unsatisfied). The questionnaires were pilot-tested
and validated by 12 patients and 12 surgeons prior to the start
of the study. An assigned co-investigator who was present
throughout the procedure administered the questionnaires.
The patients were asked to rate the pain experienced during
local anaesthetic infiltration using an ordinal visual pain scale
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right after infiltration. After the surgical procedure, the patients
were then asked to answer the remaining portions of the
questionnaire. The surgeons also answered their corresponding
questionnaires after the procedure. The primary outcomes
measured were the patients’ assessment of pain after infiltration
of anaesthesia. Secondary outcomes included patients’
assessment of pain after haemorrhoidectomy, satisfaction
with the procedure and acceptability of the cream applied.
Other secondary outcomes included the surgeon’s assessment
of the presence or absence of the anal wink reflex during
anaesthesia infiltration, plus satisfaction and acceptance of
using the cream for the procedure.
Data were encoded into the EPI INFO 2000 programme for
Windows (Centers for Disease Control and Prevention, Atlanta,
Georgia, USA). Statistical analysis included the Mann-Whitney
U-test for the non-parametric ordinal visual scales, and 2 x 2
tables, Chi-square and Fisher’s exact test for the nominal data,
as deemed appropriate. Dropouts or withdrawals were to be
analyzed in the groups to which they were allocated. Hypotheses
were tested at a level of significance of 0.05 (two-tailed).
Results
Ninety-eight patients consented to undergo outpatient
haemorrhoidectomy under local anaesthesia during the period
from July 2000 to January 2001. Forty-nine patients each were
randomly assigned to the experimental EMLA (group 1) and
placebo control (group 2) groups. The two groups were similar
in terms of gender distribution, mean age, types and grades of
the haemorrhoids and mean duration of anaesthetic
infiltration (Table 1).
The local anaesthetics were generally well tolerated, with 40
patients (82%) in group 1 and 42 patients (86%) in group 2
reporting either mild or no pain during infiltration, with a
relative risk of developing severe pain at 1.29 (95% confidence
interval (CI), 0.52, 3.18). One patient in group 2 had to be
sedated due to persistent muscle spasm and bleeding, while
another was converted to a regional block due to persistent pain.
After the haemorrhoidectomy, 44 patients (90%) in group 1 and
42 patients (86%) in group 2 reported mild to no pain at all.
In both treatment groups, 43 patients (88%) and 44 surgeons
(90%) would recommend the same procedure to other patients.
As assessed by the patients, there was no statistically
significant difference between the mean ranks of the two
groups, particularly in terms of pain scores after anaesthetic
infiltration and after haemorrhoidectomy, and satisfaction
levels with the cream and the procedure as a whole. Thirty
patients (61%) in group 1 and 33 patients (67%) in group 2
exhibited the anal wink reflex during infiltration, but this was
not statistically significant. There was also no statistically
significant difference in the comfort and satisfaction rankings
of surgeons for both groups (Tables 2 and 3).
Discussion
Haemorrhoidectomy under local anaesthesia is safe, reliable
and inexpensive.1,3 The procedure, performed under local
anaesthesia, decreased hospital stay and costs, and avoided
potential anaesthetic side-effects such as nausea, vomiting,
headache, and others. In this study, the procedure was generally
well tolerated, with the majority of patients having nil to mild
pain during anaesthetic infiltration and immediately after the
operation. Most of the study participants were willing to
undergo the same procedure again if necessary. They also
indicated that they would recommend its use in other patients.
A growing familiarity with the technique among our surgery
residents, and greater acceptability by the patients, has allowed
us to increase the number of haemorrhoidectomies that we
perform in our outpatient department (Figure).
The number of haemorrhoidectomies done under local
anaesthesia rose from a low rate of 4.9% prior to July 2000, to
52.1% during the 6-month study period, and then finally
Table 1.  Baseline characteristics of patients in the eutectic lidocaine/
prilocaine (EMLA) and placebo treatment groups
Patient EMLA Placebo p value
characteristics (n1=49) (n2=49)
Sex
     Male 29 (59.2%) 27 (55.1%)
     Female 20 (40.8%) 22 (44.9%) 0.68 (NS)
Age (mean) 33.49 36.96 0.15 (NS)
Type of haemorrhoids
     External 4 (8.2%) 2 (4.1%)
     Internal 12 (24.5%) 15 (30.6%)
     Mixed 32 (65.3%) 32 (65.3%)   0.8 (NS)
     No information 1 0
Grade of haemorrhoids
     I 3 (6.1%) 1 (2.1%)
     II   9 (18.4%) 16 (12.2%)
     III 3 (6.1%)   5 (10.2%)
     IV 32 (65.3%) 33 (67.3%) 1.0 (NS)
     No information 2 (4.1%) 4 (8.1%)
Duration of infiltration
     in seconds (mean) 284.28 295.41 0.79 (NS)
NS = not significant.
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settled down to a fairly constant rate of 47.5% after the study
period. At present, the procedure has become part of our
standard management, particularly in our setting where
inefficiencies in providing anaesthesia exist.
With an expected increase in the number of haemorrhoid-
ectomies done under local anaesthesia, we wanted to find out
if using EMLA cream would further decrease the pain associated
with anaesthetic infiltration. Favourable findings from this
study would have provided a basis for utilizing EMLA in our
treatment protocols for outpatient surgery. However, our
results do not show any significant benefit to using the topical
anaesthetic. Although this runs counter to many other studies
on EMLA, there have been a few randomized trials that have
also shown no significant difference between EMLA and
placebo.17,18
We can only hypothesize why EMLA was not as effective in
this study. For example, it may be argued that 45 minutes is too
short a period of application. Early in the protocol development,
the authors decided on the 45-minute application time
because this duration had already been established in previous
studies.15 Furthermore, a period longer than that may have
been impractical in the outpatient setting where volume and
efficient turnover of cases is a continuing concern.
The efficacy of EMLA in the perianal area requires further
study. There is a question of whether absorption of the topical
anaesthetic is possibly hindered by the natural pH gradient in
Table 2. Table for non-parametric ordinal data
EMLA Placebo Mann-Whitney U p-value
(n1 = 49) (n2 = 49) statistics (2 tailed)
I. Assessment by patient (mean)
       Pain scores after infiltration of  anaesthetic 1.47 1.37 1181.5 0.886 (NS)
       Pain scores after haemorrhoidectomy 0.9 0.8 1158.5 0.745 (NS)
       Satisfaction with the anaesthetic cream 1.47 1.49 1113.5 0.503 (NS)
       Satisfaction with the whole procedure 1.12 1.04 1185.5 0.909 (NS)
II. Assessment by surgeon (mean)
       Comfort levels of patient during infiltration of anaesthetic 2.45 2.43 1178.0 0.855 (NS)
       Satisfaction with anaesthetic 1.98 1.88 1103.0 0.424 (NS)
NS = not significant.
Table 3.  Table for dichotomous responses
 EMLA Placebo p-value RR
(n1 = 49) (n2 = 49) (associated with Fisher’s exact test) (95% CI)
Yes % Yes %
I. Assessment by patient
       Less pain 35 71.4 34 69.4 1.000 (NS) 1.017 (0.7,1.5)
       Acceptable waiting time 38 77.6 35 71.4 0.769 (NS) 0.965 (0.7,1.3)
       Recommends procedure 43 87.8 43 87.8 1.000 (NS) 1.000 (0.8,1.3)
II. Assessment by surgeon
       Anal wink (+) 30 61.2 33 67.3 0.674 (NS) 1.100 (0.7,1.7)
       Less pain 38 77.6 35 71.4 0.633 (NS) 0.921 (0.6,1.3)
       Recommends procedure 44 89.8 44 89.8 1.000 (NS) 1.000 (0.8,1.3)
CI = confidence interval; NS = not significant.
Figure. Outpatient anorectal surgery at the Philippine General
Hospital. LA = local anaesthesia; SAB = subarachnoid block.
50
45
40
35
30
25
20
15
10
5
0
N
um
be
r 
of
 p
at
ie
nt
s
Jan
-00 Ma
r
Ma
y Jul Sep No
v
Jan
-01 Ma
r
Ma
y
Period in months
■ LA   ■ SAB
30 ASIAN JOURNAL OF SURGERY  VOL 26 • NO 1 • JANUARY 2003
■ ROXAS AND OTHERS ■
that region, or by the thickened epithelium constantly exposed
to chemical irritants. The ability to apply and maintain the
EMLA cream and its corresponding occlusive dressing around
the anus and between the buttocks, despite movements while
walking, or compression while sitting, are issues that also need
to be resolved.
Ho et al did the only other study on EMLA for haemorrhoi-
dectomy that we found after a thorough Medical Subject
Headings search using MEDLINE™ and Cochrane.16 In this
randomized clinical trial, they report that the topical
anaesthetic cream with local anaesthesia did not have any
significant difference when compared to general anaesthesia
in terms of operating time, postoperative pain, nausea
or vomiting, pain-free interval after operation, analgesic
requirements, patient’s satisfaction with the method of
anaesthesia, postoperative oxygen saturation and pulse rate.
They concluded that EMLA with local anaesthesia was just
as effective as general anaesthesia. Ten grams of EMLA were
used for each patient in their study. The perioperative area
was then covered by specially prepared gauze impregnated
with paraffin. The patients were also made to rest lying on
their side. This is quite different from the technique that we
used, and may, theoretically, be more effective. Nonetheless,
the study by Ho et al was hampered by its small sample size
(27 in the EMLA group, 26 in the GA group). They reported
that 18 patients in the EMLA group (67%) experienced only
mild or no pain during injection of the anaesthetic. This
proportion is even fewer than the 86% of patients who had
mild to no pain in the placebo group in our study. Furthermore,
Ho et al evaluated EMLA and local anaesthesia versus general
anaesthesia. They did not evaluate whether or not EMLA
itself was effective, which would have required comparing it
to placebo, all other variables being equal. Based on our data,
our contention is that the pain associated with the infiltration
of local anaesthesia is well tolerated and acceptable to the
majority of patients and that adding EMLA does not confer
any significant benefit.
While outpatient haemorrhoidectomy under local
anaesthesia was generally well tolerated and acceptable in
this study, with most patients experiencing only mild pain,
there was no statistically significant difference between
EMLA and placebo in decreasing pain during anaesthetic
infiltration.
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